BiotechTube
Home/Akribion Therapeutics/Lukas Linnig
LL

Lukas Linnig

Co-Founder & Co-CEO

Akribion Therapeutics

Therapeutic Areas

OncologyAutoimmune DiseasesFibrosisInfectious Diseases

Akribion Therapeutics Pipeline

DrugIndicationPhase
G-dase E for HPV+ OPSCCHPV-induced Oropharyngeal Head & Neck Cancer (OPSCC)Pre-clinical

Leadership Team at Akribion Therapeutics

MK
Michael Krohn
Co-Founder & Co-CEO
DP
Dr. Paul Scholz
Head of Research and Development
View full Akribion Therapeutics profile